News sentiment analysis powered by sentiment-insight.com
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q3 2023 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q3 2023 Earnings Call Transcript. Use of this call is strictly prohibited. This call is being webcast live on the Investors and Media section of Sages' website at sagerx.com.
'Professor Lockdown' Neil Ferguson denies ever calling for lockdown but admits 'stepping outside'... Professor Neil Ferguson's March 2020 models warned 500,000 Brits would die unless tougher action was taken to curb the virus's spread. It spooked Boris Johnson into adopting draconian restrictions that saw the country told they'must stay at home. Professor Ferguson quit his role as a SAGE adviser two months after being caught breaking social distancing rules to meet his married lover.
Transgender adults are worried about finding welcoming... About 171,000 of the more than 1.3 million transgender adults in the United States are aged 65 and older. SAGE has seen a spike in the number of calls to its hotline following the wave of anti-transgender laws. At least 22 states banning or restricting gender-affirming care for minors.
Sovos Brands, Elanco Animal Health rise; Tyson Foods, Gogo fall, Monday, 8/7/2023 | AP News Campbell Soup is buying the maker of Rao’s pasta sauces in a deal worth about $2.7 billion. Veritiv Corp. (VRTV), up $28.09 to $169.30. Sage Therapeutics Inc. (SAGE), down $18.78 to $17.32.
Ministers 'ignored warning suicides would kill many more children than Covid' Suicide killed nearly five times more children than Covid did in 2020. SAGE scientists warned that closing schools during the pandemic would likely have a "highly limited" impact on Covid transmission rates.
Healthy kids, teens at low risk of COVID: WHO WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) released new guidelines on which groups of people should prioritize receiving a COVID-19 vaccine. The high priority group includes older adults, younger adults with significant comorbidities, people with immunocompromising conditions, pregnant people and frontline health workers.
What do experts on the Government's SAGE panel hink the next pandemic will be? MailOnline put the question to experts who sat on the Scientific Advisory Group for Emergencies (SAGE) panel during the Covid crisis.
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb? The FDA has accepted for review a marketing application seeking approval for Sage Therapeutics Inc SAGE and Biogen Inc's BIIB zuranolone for major depressive disorder (MDD) and postpartum depression (PPD) The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of August 5, 2023.
Sage Therapeutics (NASDAQ:SAGE) shareholders are up 5.6% this past week, but still in the red over the last five years Sage Therapeutics, Inc. (NASDAQ:SAGE) didn't make a profit in the last twelve months. The stock has risen 5.6% in the past week but long term shareholders are still in the red. Shareholders of unprofitable companies usually expect strong revenue growth.
Sign Up
